We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Educational Materials Required as Part of Risk-Mitigation Strategies, EMA Says
Educational Materials Required as Part of Risk-Mitigation Strategies, EMA Says
Drugmakers in Europe will need to submit proposed educational materials in a specific format and with specified content as part of their risk-mitigation strategy, under a draft addendum to the European Medicines Agency’s good pharmacovigilance practices guidelines.